Reuters logo
BRIEF-Obseva SA announces completion of early stage trial evaluating endometriosis drug
2017年6月7日 / 上午11点27分 / 5 个月前

BRIEF-Obseva SA announces completion of early stage trial evaluating endometriosis drug

June 7 (Reuters) - Obseva sa-

* Obseva SA announces the completion of a phase 1 pk/pd clinical trial evaluating different doses of obe2109 and add-back therapy

* Obseva SA - all regimens in phase 1 pk/pd clinical trial were well-tolerated and no safety signal emerged Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below